# A Survey of Susoctocog Alfa (Genetical Recombination) in Participants With Acquired Haemophilia A

> **NCT06461533** · — · RECRUITING · sponsor: **Takeda** · enrollment: 25 (estimated)

## Conditions studied

- Acquired Hemophilia A

## Interventions

- **DRUG:** Susoctocog Alfa (Genetical Recombination)

## Key facts

- **NCT ID:** NCT06461533
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-10
- **Primary completion:** 2029-10-31
- **Final completion:** 2029-10-31
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2025-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06461533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06461533, "A Survey of Susoctocog Alfa (Genetical Recombination) in Participants With Acquired Haemophilia A". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06461533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*